Article info
PDFOriginal research
Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitors
- Correspondence to Dr Shira Peleg Hasson, Faculty of Medicine, Tel Aviv University, Tel Aviv, Tel Aviv, Israel; shiraph{at}tlvmc.gov.il
Citation
Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitors
Publication history
- Received September 7, 2023
- Accepted December 13, 2023
- First published January 19, 2024.
Article Versions
- View the most recent version of this article
- You are currently viewing a Previous version of this article (1 April 2024).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.